[1] |
Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases[J]. Hepatology, 2017, 65(1):310-335.
|
[2] |
D'Amico G, Morabito A, D'Amico M, et al. Clinical states of cirrhosis and competing risks[J]. J Hepatol, 2018, 68(3):563-576.
|
[3] |
Butt AA, Ren Y, Lo Re V 3rd, et al. Comparing Child-Pugh, MELD, and FIB-4 to predict clinical outcomes in hepatitis C virus-infected persons: results from ERCHIVES [J]. Clin Infect Dis, 2017, 65(1):64-72.
|
[4] |
张明明, 张岭漪. 吲哚菁绿清除试验评估肝储备功能的应用价值[J]. 临床肝胆病杂志, 2019, 35(8):1878-1881.
|
[5] |
Suresh K, Owen D, Bazzi L, et al. Using indocyanine green extraction to predict liver function after stereotactic body radiation therapy for hepatocellular carcinoma[J]. Int J Radiat Oncol Biol Phys, 2018, 100(1):131-137.
|
[6] |
Vos JJ, Wietasch JK, Absalom AR, et al. Green light for liver function monitoring using indocyanine green? an overview of current clinical applications[J]. Anaesthesia, 2014, 69(12):1364-1376.
|
[7] |
Raoul JL, Forner A, Bolondi L, et al. Updated use of TACE for hepatocellular carcinoma treatment: how and when to use it based on clinical evidence[J]. Cancer Treat Rev, 2019(72):28-36.
|
[8] |
刘倩, 符建. 超声诊断肝硬化患者门、脾静脉血流动力学与肝功能、胆囊壁增厚程度的相关性分析[J]. 肝脏, 2020, 25(6):633-635.
|
[9] |
王丹, 张国辉, 丁龙垲. 彩色多普勒超声对肝硬化与胆囊病变关系的探讨[J]. 中国超声诊断杂志, 2004, 5(5):388-389.
|
[10] |
刘影. 超声测量胆囊壁厚度与慢性肝病的关系[J]. 影像研究与医学应用, 2019, 3(19): 244-245.
|
[11] |
李迎峰, 韩巧林. 肝硬化胆囊改变的CT分析[J]. 长治医学院学报, 2015(1):43-45.
|
[12] |
Levesque E, Martin E, Dudau D, et al. Current use and perspective of indocyanine green clearance in liver diseases[J]. Anaesth Crit Care Pain Med, 2016, 35(1):49-57.
|
[13] |
康玮玮, 周莉, 刘旭华, 等. 肝硬化患者吲哚菁绿清除试验的临床评价[J]. 中华消化外科杂志, 2009, 8(4):300-301.
|
[14] |
Møller S, la Cour Sibbesen E, Madsen JL, et al. Indocyanine green retention test in cirrhosis and portal hypertension: accuracy and relation to severity of disease[J]. J Gastroenterol Hepatol, 2019, 34(6):1093-1099.
|
[15] |
刘精华, 刘娜, 刘晨希. 吲哚菁绿15分钟滞留率对HBV相关慢加急性肝衰竭患者病情及预后的评估价值[J]. 临床肝胆病杂志, 2016, 32(11):2155-2158.
|
[16] |
秦华, 万红, 吴晓庆, 等. 吲哚菁绿清除试验对肝硬化及肝衰竭患者肝脏储备功能的评估及预后的判断[J]. 中华肝脏病杂志, 2015, 23(7):540-542.
|
[17] |
Feng HL, Li Q, Wang L, et al. Indocyanine green clearance test combined with MELD score in predicting the short-term prognosis of patients with acute liver failure[J]. Hepatobiliary Pancreat Dis Int, 2014, 13(3):271-275.
|
[18] |
Kobayashi Y, Kiya Y, Nishioka Y, et al. Indocyanine green clearance of remnant liver (ICG-Krem) predicts postoperative subclinical hepatic insufficiency after resection of colorectal liver metastasis: theoretical validation for safe expansion of Makuuchi's criteria[J]. HPB, 2020, 22(2):258-264.
|
[19] |
Tang Y, Han M, Chen M, et al. Donor indocyanine green clearance test predicts graft quality and early graft prognosis after liver transplantation[J]. Dig Dis Sci, 2017, 62(11):3212-3220.
|
[20] |
Zarrinpar A, Lee C, Noguchi E, et al. A rapid, reproducible, noninvasive predictor of liver graft survival[J]. J Surg Res, 2015, 197(1):183-190.
|
[21] |
Wang W, Zhao Q, Hu A, et al. Application of indocyanine green (ICG) detection in evaluating early prognosis in patients with fatty liver disease after liver transplantation[J]. Ann Transplant, 2017(22):208-214.
|